Considerations for Allowing the Government to Negotiate Drug Prices in Medicare Part D

Considerations for Allowing the Government to Negotiate Drug Prices in Medicare Part D

Medicare Part D premiums will increase by 13 percent in 2016, with beneficiaries expected to pay, on average, more than $41 a month for prescription drug coverage. These rising costs—coupled with an increasing number of pricey drugs being placed on specialty tiers within formularies, where out-of-pocket expenses are highest—have spurred discussion around whether laws should be changed to allow the government to negotiate drug prices in Medicare Part D.

In a new Health Affairs blog, experts from The Pew Charitable Trusts examine this policy proposal, urging that policymakers must first consider three questions:

  1. Which drugs would the government have the authority to negotiate?
  2. Would the government be able to negotiate both drug price and formulary design?
  3. Would the negotiated price apply to all Medicare Part D plans?

Read the Health Affairs blog

The front facade of the Supreme Court of the United States in Washington, DC.
ian-hutchinson-U8WfiRpsQ7Y-unsplash.jpg_master

Agenda for America

A collection of resources to help federal, state, and local decision-makers set an achievable agenda for all Americans

Quick View

Data-driven policymaking is not just a tool for finding new solutions for emerging challenges, it makes government more effective and better able to serve the public interest. In the coming months, President Joe Biden and the 117th Congress will tackle a number of environmental, health, public safety, and fiscal and economic issues—nearly all of them complicated by the COVID-19 pandemic. To help solve specific, systemic problems in a nonpartisan fashion, Pew has compiled a series of briefings and recommendations based on our research, technical assistance, and advocacy work across America.

Lightbulbs
Lightbulbs

States of Innovation

Data-driven state policy innovations across America

Quick View

Data-driven policymaking is not just a tool for finding new solutions for difficult challenges. When states serve their traditional role as laboratories of innovation, they increase the American people’s confidence that the government they choose—no matter the size—can be effective, responsive, and in the public interest.